Hardy Reed LLC significantly reduced its stake in Merck & Co., Inc. by selling 8,831 shares, leaving it with 6,507 shares valued at $546,000. This follows recent insider selling by EVP Jennifer Zachary and CEO Robert M. Davis, totaling 320,176 shares worth approximately $38.3 million by insiders in the last three months. Despite insider exits, Merck maintains an average “Moderate Buy” rating from analysts with a target price of $123.71, recently beat Q4 EPS estimates, and announced a $0.85 quarterly dividend.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Hardy Reed LLC Sells 8,831 Shares of Merck & Co., Inc. $MRK
Hardy Reed LLC significantly reduced its stake in Merck & Co., Inc. by selling 8,831 shares, leaving it with 6,507 shares valued at $546,000. This follows recent insider selling by EVP Jennifer Zachary and CEO Robert M. Davis, totaling 320,176 shares worth approximately $38.3 million by insiders in the last three months. Despite insider exits, Merck maintains an average “Moderate Buy” rating from analysts with a target price of $123.71, recently beat Q4 EPS estimates, and announced a $0.85 quarterly dividend.